Standout Papers

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease 2015 2026 2018 2022 2.0k
  1. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease (2016)
    Giampaolo Bianchini, Justin M. Balko et al. Nature Reviews Clinical Oncology
  2. Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer (2019)
    Fabrice André, Eva Ciruelos et al. New England Journal of Medicine
  3. The PI3K/AKT Pathway as a Target for Cancer Treatment (2015)
    Ingrid A. Mayer, Carlos L. Arteaga Annual Review of Medicine
  4. Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer (2019)
    Aditya Bardia, Ingrid A. Mayer et al. New England Journal of Medicine
  5. Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1 (2020)
    Fabrice André, Eva Ciruelos et al. Annals of Oncology

Immediate Impact

7 by Nobel laureates 9 from Science/Nature 66 standout
Sub-graph 1 of 19

Citing Papers

Immune checkpoint therapy—current perspectives and future directions
2023 StandoutNobel
Deciphering breast cancer: from biology to the clinic
2023 Standout
27 intermediate papers

Works of Ingrid A. Mayer being referenced

Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Alpelisib Plus Fulvestrant in PIK3CA -Altered and PIK3CA -Wild-Type Estrogen Receptor–Positive Advanced Breast Cancer
2018
and 15 more

Author Peers

Author Last Decade Papers Cites
Ingrid A. Mayer 5832 3165 4896 3285 207 11.6k
Sarat Chandarlapaty 5812 3963 6188 2878 201 12.2k
Federico Rojo 7491 3253 6966 2523 263 13.2k
Alberto Ocaña 7114 2462 3696 2453 296 12.0k
Jungsil Ro 7720 5123 3425 3610 190 13.1k
Angelo Di Leo 9688 4372 4024 5062 309 14.0k
George Somlo 5849 1703 4486 3581 275 11.7k
P. Fumoleau 9431 2609 3207 4272 324 14.0k
Joan Albanell 7586 2802 4709 2674 248 12.1k
Maurizio Scaltriti 6154 2916 5814 2042 141 11.6k
Sara A. Hurvitz 7870 4084 3119 2491 367 10.6k

All Works

Loading papers...

Rankless by CCL
2026